Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFTR | P13569 | 20/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL6283442 | 0.96 | CFTR (0.61) | CFTR | |
| Trifluoroacetic Acid SCHEMBL6494633 | 0.95 | CFTR (0.58) | CFTR | |
| Trifluoroacetic Acid SCHEMBL6493737 | 0.95 | CFTR (0.55) | CFTR | |
| Trifluoroacetic Acid SCHEMBL6493741 | 0.95 | CFTR (0.55) | CFTR | |
| Trifluoroacetic Acid SCHEMBL6280456 | 0.91 | CFTR (0.53) | CFTR | |
| SCHEMBL6278783 | 0.89 | CFTR (0.70) | CFTR | |
| Trifluoroacetic Acid SCHEMBL6504278 | 0.89 | CFTR (0.57) | CFTR | |
| Trifluoroacetic Acid SCHEMBL6504281 | 0.89 | CFTR (0.57) | CFTR | |
| Trifluoroacetic Acid SCHEMBL6281223 | 0.89 | CFTR (0.70) | CFTR | |
| Trifluoroacetic Acid SCHEMBL6280982 | 0.89 | CFTR (0.63) | CFTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050288316-A1 | Beta-carbolines as growth hormone secretagogue receptor (GHSR) antagonists | BIOVITRUM AB (SE) | 2005-12-29 | — | — | US | claimed |
| WO-2005048916-A2 | TETRAHYDROSPIRO-BETA-CARBOLINE-1,3 '-PYRROLIDINE DERIVATIVES AND THEIR USE IN GHSR-RELATED DISORDERS | BIOVITRUM AB (SE) | 2005-06-02 | — | — | WO | claimed |
| US-20050288316-A1 | Beta-carbolines as growth hormone secretagogue receptor (GHSR) antagonists | BIOVITRUM AB (SE) | 2005-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288316-A1 | Beta-carbolines as growth hormone secretagogue receptor (GHSR) antagonists | GHSR, GHRHR, PRLHR | CFTR 589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.